マイクロアレイ解析市場規模、シェア、成長分析：製品別、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

マイクロアレイ解析市場規模は2023年に37億米ドルと評価され、2024年の39億9,000万米ドルから2032年には73億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.9%で成長する見通しです。

世界のマイクロアレイ解析市場は、技術の進歩と個別化医療のニーズの高まりに後押しされ、大きな成長を遂げています。このハイスループット技術は、ゲノム研究の進歩や慢性疾患の増加などの要因によって、何千もの遺伝子を同時に調べることを可能にします。主なアプリケーションには、遺伝子発現プロファイリング、ジェノタイピング、バイオマーカー探索などがあり、大規模な遺伝子研究や創薬を可能にすることで、ゲノミクスや分子生物学研究に変革をもたらしました。マイクロアレイ解析と次世代シーケンシングやバイオインフォマティクスなどの新技術との相乗効果が、市場拡大をさらに後押ししています。北米は強固な研究インフラにより依然として支配的な市場であるが、アジア太平洋地域は、新興経済国がマイクロアレイ技術を採用し、個別化医療と診断における継続的な技術革新のために市場を位置づけているため、急速な成長が見込まれています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

マイクロアレイ解析市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 消耗品
• 機器
• ソフトウェア
• サービス

マイクロアレイ解析市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• DNAマイクロアレイ
• タンパク質マイクロアレイ
• その他

マイクロアレイ解析市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 調査
• 創薬
• 病気の診断
• その他の用途

マイクロアレイ解析市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 調査・学術機関
• 製薬・バイオテクノロジー企業
• 診断検査室
• その他

マイクロアレイ解析市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Illumina, Inc.（United States）
• Agilent Technologies, Inc.（United States）
• Thermo Fisher Scientific, Inc.（United States）
• Merck KGaA（Germany）
• PerkinElmer, Inc.（United States）
• Arrayit Corporation（United States）
• Bio-Rad Laboratories, Inc.（United States）
• GE Healthcare（United States）
• Molecular Devices, LLC.（United States）
• Affymetrix（United States）
• Applied Microarrays, Inc.（United States）
• Oxford Gene Technology（United Kingdom）
• CapitalBio Corporation（China）
• Macrogen, Inc.（South Korea）
• LC Sciences（United States）
• Scienion AG（Germany）
• Arrayjet Ltd.（United Kingdom）
• RayBiotech, Inc.（United States）
• Genotypic Technology Pvt. Ltd.（India）
• Microarrays Inc.（United States）

結論と提言

Microarray Analysis Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.99 billion in 2024 to USD 7.33 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global Microarray Analysis Market is experiencing significant growth, fueled by technological advancements and the rising need for personalized medicine. This high-throughput technique allows for the simultaneous examination of thousands of genes, driven by factors like genomic research advancements and the increasing incidence of chronic diseases. Key applications include gene expression profiling, genotyping, and biomarker discovery, which have transformed genomics and molecular biology research by enabling large-scale gene studies and drug discovery. The synergy between microarray analysis and emerging technologies such as next-generation sequencing and bioinformatics further propels market expansion. While North America remains the dominant player due to robust research infrastructure, the Asia-Pacific region is set for rapid growth as emerging economies embrace microarray technologies, positioning the market for ongoing innovation in personalized medicine and diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microarray Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microarray Analysis Market Segments Analysis

Global Microarray Analysis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Type, the market is segmented into DNA Microarray, Protein Microarray and Others. Based on Application, the market is segmented into Rese arch Applications, Drug Discovery, Disease Diagnostics and Others Applications. Based on End User, the market is segmented into Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Microarray Analysis Market

A significant catalyst for the Global Microarray Analysis Market is the rising demand for personalized medicine. This innovative medical approach focuses on customizing treatments for individual patients by taking into account their unique genetic profiles, leading to more accurate and effective therapeutic strategies. In this context, microarray analysis is essential, as it delivers extensive genomic data and assists in pinpointing genetic variations linked to diseases. As personalized medicine continues to gain traction globally, the need for microarray analysis technology intensifies, further propelling market expansion and innovation in the field of genomics and healthcare.

Restraints in the Microarray Analysis Market

A significant limitation facing the Global Microarray Analysis Market is the substantial financial burden linked to microarray technologies and their analysis. The expense associated with microarray platforms, reagents, and instruments can render them inaccessible to numerous research institutions and healthcare facilities that operate under tight budget constraints. Furthermore, the intricate nature of data analysis, combined with the necessity for specialized knowledge, exacerbates the cost issue. This financial challenge is particularly pronounced in resource-limited contexts, stifling broader adoption and growth within the market. Addressing this restraint requires efforts aimed at cost reduction and enhancing affordability through technological innovations and optimized workflows.

Market Trends of the Microarray Analysis Market

The Global Microarray Analysis Market is currently witnessing a notable trend characterized by the integration of microarray technologies with other omics platforms, particularly next-generation sequencing (NGS) and advanced bioinformatics tools. This convergence enhances data analysis capabilities, enabling researchers to achieve a holistic view of biological systems through a detailed examination of the genome, transcriptome, and epigenome. By combining these powerful technologies, scientists can gain deeper insights into gene expression, genetic variations, and complex biological processes related to diseases and personalized medicine. This trend not only promotes innovative research methodologies but also drives the demand for integrated solutions that facilitate multi-dimensional molecular profiling, positioning microarray analysis as a vital component in the evolving landscape of genomics and biotechnology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Microarray Analysis Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments
• Software
• Services

Global Microarray Analysis Market Size by Type & CAGR (2025-2032)

• Market Overview
• DNA Microarray
• Protein Microarray
• Others

Global Microarray Analysis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research Applications
• Drug Discovery
• Disease Diagnostics
• Others Applications

Global Microarray Analysis Market Size by End User & CAGR (2025-2032)

• Market Overview
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Others

Global Microarray Analysis Market Size & CAGR (2025-2032)

• North America (Product & Services, Type, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arrayit Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Microarrays, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Gene Technology (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapitalBio Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LC Sciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scienion AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arrayjet Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genotypic Technology Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microarrays Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations